查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018716

結構生物學與分子建模技術市場：2026-2032年全球市場預測（按技術、產品類型、工作流程階段、應用和最終用戶分類）

Structural Biology & Molecular Modeling Techniques Market by Technique, Product Type, Workflow Step, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，結構生物學和分子建模技術市場價值將達到 132 億美元，到 2026 年將成長到 155.4 億美元，到 2032 年將達到 442.4 億美元，複合年成長率為 18.85%。

主要市場統計數據
基準年 2025 132億美元
預計年份：2026年 155.4億美元
預測年份 2032 442.4億美元
複合年成長率 (%) 18.85%

本書清晰權威地介紹了實驗方法與計算方法結合如何重新定義結構生物學和分子建模的實踐。

結構生物學和分子建模已成為現代生命科學研究的基石，使得原子層級的洞見能夠轉化為具體的治療方法和診斷進展。過去十年間，高解析度實驗技術與先進計算方法的融合，徹底改變了我們對大分子結構、動力學和相互作用的理解。本書將這些關鍵技術置於更廣泛的研究生態系統中，清楚地展示了它們之間的互補作用，並著重強調了它們對學術界、生物技術公司、受託研究機構和產業界等相關人員的實際意義。

快速的技術融合和調查方法的整合如何重塑結構生物學的實驗工作流程並加速轉化應用？

結構生物學和分子建模領域正經歷著一場變革性的轉變，這主要得益於設備的創新、演算法的突破以及研究流程的改進。高通量自動化和樣品處理技術的進步正在加速資料生成，而影像處理和頻譜反捲積演算法的改進則縮短了獲得洞見所需的時間。深度學習技術改變了人們對計算模型預測能力的預期，使研究人員能夠產生合理的結構假設，並透過有針對性的實驗表徵檢驗這些假設。因此，傳統的實驗與計算二分法正在消融，取而代之的是一個持續迭代的循環：In Silico模擬預測指導實驗設計，而實驗數據則用於改進計算模型。

本研究分析了關稅導致的採購趨勢變化和供應鏈調整如何重塑結構生物學領域的儀器採購、供應商策略和區域夥伴關係。

政策和貿易趨勢，包括關稅措施，會影響結構生物學研究中使用的儀器、試劑和軟體的籌資策略、供應鏈和供應商選擇。關稅會改變進口儀器和耗材的相對成本結構，鼓勵在地採購，並促進策略儲備和期貨合約，以降低採購風險。對於研究機構和營運國際供應鏈的公司而言，這些貿易政策的變化需要重新評估採購計畫、供應商多元化策略以及與儀器購置相關的資金配置決策。

一個全面的細分框架，將技術、產品類型、應用、最終用戶和工作流程階段與策略部署和能力建構重點連結起來。

細分市場提供了一個分析框架，用於理解結構生物學研究的各個階段——技術、產品類型、應用、最終用戶和工作流程——如何影響技術採納、產能投資和服務需求。基於技術，市場分析涵蓋計算建模、冷凍電鏡、質譜、核磁共振波譜和X光晶體學等領域。具體而言，計算建模細分為第一原理計算、同源建模和分子動力學；冷凍電子顯微鏡細分為單顆粒分析和斷層掃描；質譜細分為電灑電離和MALDI-TOF；核磁共振波譜細分為固體和溶液方法；X光晶體學細分為粉末和單晶方法。這種多模態觀點突顯了實驗和計算優勢如何應對特定的科學挑戰，每項子技術在通量、解析度和樣品需求方面都各有優劣。

區域趨勢和生態系統差異決定了全球研究中心的模式採用、夥伴關係結構和基礎設施優先事項。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的研究方法、夥伴關係和研究生態系統結構產生了顯著影響。在美洲，主要的學術研究中心、密集的生物技術產業和成熟的製藥叢集，共同造就了對尖端設備和專業服務的高需求環境，從而促進了當地供應商的蓬勃發展和合作聯盟模式的形成。這種區域格局鼓勵儘早採用綜合方法，並推動從結構性洞察到治療方法開發的穩健轉化流程。

從儀器、軟體、試劑到服務，供應商的策略、夥伴關係和整合解決方案組合如何重塑競爭格局和價值主張。

該領域的發展趨勢受到由儀器製造商、軟體開發商、試劑供應商和服務型機構組成的複雜供應商生態系統的影響。主要儀器供應商持續投資於高通量、高靈敏度和自動化技術，以滿足實驗室多樣化的需求；軟體公司則專注於互通性，以促進跨學科協作、雲端工作流程和使用者友善介面。試劑和耗材供應商致力於提高產品的穩健性、批間一致性以及與自動化工作流程的兼容性；而服務供應商和受託研究機構則憑藉其專業知識、準時交付和提供整合式多技術方案而脫穎而出。

為領導者提供切實可行的建議，以增強跨整合工作流程的互通性、人才能力、採購韌性和資料管治。

產業領導者應著重採取切實可行的措施，以提高整合結構生物學工作流程的效率和科學影響力。首先，優先考慮計算平台和實驗平台之間的互通性，可以減少摩擦並加快檢驗週期。透過採用開放標準並投資於主導API 的整合，各機構可以縮短從預測到實驗檢驗的流程。其次，投資人才培養和跨學科培訓，能夠幫助團隊利用先進技術並有效解讀複雜的資料集。持續的教育項目和有針對性的技能提升可以消除操作瓶頸並提高可重複性。

採用透明、嚴謹的混合方法研究途徑，結合專家訪談、技術文獻整合、比較矩陣與應用檢驗練習。

本調查方法結合了文獻整合、專家訪談、技術趨勢分析以及基於實際應用案例的檢驗，以確保分析的嚴謹性和實用性。關鍵的定性資料包括對學術研究人員、核心設施管理人員、生物技術和製藥公司的研究負責人以及測量和軟體公司技術負責人的結構化訪談。這些訪談深入探討了該方法的技術評估、運行限制以及其應用促進因素。二級資訊來源包括同行評審文獻、會議論文集、技術白皮書和供應商資料，從而對功能、典型應用和最新進展進行了多方面的檢驗。

簡明扼要的結論強調了實施綜合結構生物學方法以實現永續的科學和轉化成果所面臨的策略挑戰。

綜上所述，這些證據凸顯了該領域向整合化、數據驅動的結構發現工作流程發展的惡性循環。實驗技術的進步與計算科學的創新相輔相成，拓展了可解決的生物學難題範圍，並加速了轉化應用的影響。優先考慮互通性、人才能力和穩健採購的相關人員最有能力將技術可能性轉化為可重複的科學成果和策略優勢。隨著方法論的互補性日益增強，各組織將從精心建構的多方法流程中獲得最大價值，這些流程需根據特定的科學目標和營運限制量身定做。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 結構生物學與分子建模技術市場：依技術分類

  • 計算建模
    • 第一原理建模
    • 同源建模
    • 分子動力學
  • 冷凍電鏡
    • 單顆粒分析
    • 斷層掃描
  • 質譜分析
    • ESI
    • MALDI-TOF
  • 核磁共振波譜
    • 固體核磁共振
    • 溶液核磁共振
  • X光晶體結構分析
    • 粉末
    • 單晶

第9章 結構生物學與分子建模技術市場：依產品類型分類

  • 裝置
  • 試劑和耗材
    • 酵素
    • 成套工具
  • 服務
  • 軟體

第10章：結構生物學與分子建模技術市場各階段工作流程

  • 數據收集
    • 自動收集
    • 人工採集
  • 資料處理
  • 樣品製備
  • 視覺化

第11章 結構生物學與分子建模技術市場：按應用領域分類

  • 生物標記發現
  • 藥物發現
    • 先導化合物的鑑定
    • 先導藥物最適化
  • 蛋白質工程
  • 結構-功能分析

第12章 結構生物學與分子建模技術市場：依最終使用者分類

  • 學術研究機構
  • 生技公司
  • 合約研究機構
  • 製藥公司

第13章 結構生物學與分子建模技術市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 結構生物學與分子建模技術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 結構生物學與分子建模技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國結構生物學與分子建模技術市場

第17章：中國結構生物學與分子建模技術市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Atomwise Inc.
  • BioSolveIT GmbH
  • Biosym Technologies
  • Certara, LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Cresset BioMolecular Discovery Ltd.
  • Cresset Group Limited
  • Cyclica Inc.
  • Cytiva
  • Dassault Systemes SE
  • Genedata AG
  • Moleculon, Inc.
  • Molsoft LLC
  • NanoTemper Technologies GmbH
  • Nimbus Therapeutics, Inc.
  • OpenEye Scientific Software, Inc.
  • Relay Therapeutics, Inc.
  • Schrodinger, Inc.
  • Simulations Plus, Inc.
  • Tripos International
Product Code: MRR-AD36CD8984FF

The Structural Biology & Molecular Modeling Techniques Market was valued at USD 13.20 billion in 2025 and is projected to grow to USD 15.54 billion in 2026, with a CAGR of 18.85%, reaching USD 44.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.20 billion
Estimated Year [2026] USD 15.54 billion
Forecast Year [2032] USD 44.24 billion
CAGR (%) 18.85%

A clear and authoritative introduction to how integrated experimental and computational approaches are redefining structural biology and molecular modeling practice

Structural biology and molecular modeling have emerged as cornerstones of modern life sciences research, enabling the translation of atomic-level understanding into tangible therapeutic and diagnostic advances. Over the past decade, the convergence of high-resolution experimental modalities and sophisticated computational approaches has reshaped how macromolecular structure, dynamics, and interactions are interrogated. This introduction situates the major techniques in the broader research ecosystem, articulates their complementary roles, and highlights the practical implications for stakeholders across academia, biotech, contract research providers, and industry.

Advances in cryo-electron microscopy have made it possible to visualize complex assemblies in near-native conditions, while X-ray crystallography continues to provide unparalleled precision for many ligand-bound states. Nuclear magnetic resonance spectroscopy offers dynamic and solution-state insights that are critical for understanding conformational ensembles, and mass spectrometry has matured into a versatile platform for structural proteomics and cross-linking analysis. Concurrently, computational modeling bridges experimental gaps through ab initio structure prediction, homology-derived models, and molecular dynamics simulations that reveal conformational landscapes. Together, these modalities form a robust toolkit that accelerates hypothesis testing, target validation, and rational design, setting the stage for the deeper explorations detailed in subsequent sections.

How rapid technological convergence and methodological integration are reshaping experimental workflows and accelerating translational applications in structural biology

The landscape of structural biology and molecular modeling is undergoing transformative shifts driven by innovation in instrumentation, algorithmic breakthroughs, and changes in research workflows. High-throughput automation and sample-handling advances are increasing the cadence of data generation, while algorithmic improvements in image processing and spectral deconvolution are reducing time-to-insight. Deep learning methods have altered expectations for what computational models can predict, enabling researchers to generate plausible structural hypotheses that are subsequently validated by targeted experimental characterization. As a result, the classical dichotomy between experiment and computation is dissolving into a continuous iterative loop where in silico predictions inform experimental design and experimental data refine computational models.

Simultaneously, the emphasis on integrative structural biology is reshaping stakeholder behavior. Users increasingly favor cross-platform strategies that combine cryo-electron microscopy, X-ray crystallography, NMR, mass spectrometry, and computational modeling to build coherent structural narratives. This compositional approach enables the interrogation of large complexes, transient interactions, and heterogeneous ensembles that single modalities struggle to resolve alone. Furthermore, software ecosystems are converging toward interoperable pipelines, enabling more reproducible and shareable analyses. The net effect is an environment where innovation cycles are compressed, collaborative science is more feasible across geographies, and translational applications-from biomarker discovery to protein engineering-benefit from richer structural context.

Analyzing how tariff-driven procurement shifts and supply-chain adjustments are reshaping equipment sourcing, vendor strategies, and regional partnerships in structural biology

Policy and trade dynamics, including tariff measures, can influence procurement strategies, supply chains, and vendor selection for equipment, reagents, and software used in structural biology research. Tariffs may alter the relative cost structure of imported instruments and consumables, prompt localized sourcing initiatives, and encourage strategic stockpiling or forward contracting to mitigate procurement risk. For research organizations and companies that operate international supply chains, these trade policy shifts necessitate revisiting procurement timelines, vendor diversity strategies, and capital allocation decisions related to instrumentation acquisition.

Importantly, tariffs can stimulate alternative behaviors beyond immediate cost management. Organizations may accelerate investments in regional partnerships and local service providers to reduce exposure to cross-border tariffs, while suppliers may adjust their commercial models by expanding local manufacturing, altering distribution agreements, or reconfiguring after-sales service networks. In parallel, academic and commercial consortia may intensify shared instrumentation and core facility models to optimize capital utilization. Although tariffs are only one element of a broader policy environment, their presence encourages greater supply-chain resilience, diversified sourcing, and heightened attention to total cost of ownership for high-value capital equipment and critical consumables.

Comprehensive segmentation framing that links techniques, product categories, applications, end users, and workflow steps to strategic adoption and capability priorities

Segmentation provides the analytical scaffolding for understanding how technique, product type, application, end user, and workflow step shape adoption, capability investment, and service demand across structural biology endeavors. Based on technique, the market is examined across computational modeling, cryo-electron microscopy, mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallography, where computational modeling subdivides into ab initio modeling, homology modeling, and molecular dynamics, cryo-electron microscopy further differentiates into single particle analysis and tomography, mass spectrometry separates into electrospray ionization and MALDI-TOF methods, NMR spectroscopy distinguishes solid-state and solution approaches, and X-ray crystallography distinguishes powder and single-crystal techniques. This multi-modal lens highlights how experimental and computational strengths map to specific scientific questions, with each sub-technique offering distinct trade-offs in throughput, resolution, and sample requirements.

In terms of product type, instruments, reagents and consumables, services, and software represent core categories, with reagents and consumables further characterized by enzymes and kits that enable routine assays and specialized workflows. Application-driven segmentation spans biomarker discovery, drug discovery, protein engineering, and structure-function analysis, and within drug discovery there is a distinction between lead identification and lead optimization activities that place different demands on accuracy, throughput, and predictive modeling. End users include academic research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies, each presenting unique adoption drivers tied to funding models, translational timelines, and regulatory expectations. Finally, segmentation by workflow step-data collection, data processing, sample preparation, and visualization-captures operational realities, with data collection itself further described by automated versus manual collection approaches that influence reproducibility, throughput, and staffing requirements. Together, these segmentation perspectives illuminate where investments in instrumentation, software, or service capabilities will yield the greatest scientific and commercial return, and clarify how providers can align offerings to meet the nuanced needs of diverse user cohorts.

Regional dynamics and ecosystem differences that determine modality adoption, partnership structures, and infrastructure priorities across global research hubs

Regional dynamics materially influence method adoption, partnerships, and the structure of research ecosystems across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, leading academic centers, a dense biotechnology sector, and established pharmaceutical clusters create a high-density demand environment for both cutting-edge instrumentation and specialist services, which supports vibrant local vendor activity and collaborative consortia models. This regional configuration favors early adoption of integrative approaches and fosters strong translational pipelines from structural insight to therapeutic development.

The Europe, Middle East & Africa region demonstrates heterogeneity in research capacity and regulatory contexts, where established hubs in Western Europe coexist with rapidly growing capabilities in other subregions. Collaborative networks, shared infrastructure initiatives, and funding frameworks that emphasize cross-border projects promote technology diffusion and specialized core facilities. In contrast, the Asia-Pacific region is characterized by substantial investment in research infrastructure, rapid expansion of industrial R&D, and increasing local manufacturing and software development capacity. This environment encourages scale and cost-efficiency, while also driving demand for services that support high-throughput and translational research pipelines. Taken together, these regional patterns suggest differentiated strategies for engagement, with considerations for local service models, regulatory alignment, and partnership architectures that enable sustained adoption and impact.

How vendor strategies, partnerships, and integrated solution portfolios are reshaping competition and value delivery across instruments, software, reagents, and services

Company behavior in this domain is shaped by a mix of instrument manufacturers, software developers, reagent suppliers, and service-oriented organizations that together form a complex vendor ecosystem. Leading instrument providers continue to invest in higher throughput, improved sensitivity, and automation to meet the needs of diverse laboratories, while software firms emphasize interoperability, cloud-enabled workflows, and user-friendly interfaces that facilitate cross-disciplinary collaboration. Reagent and consumable suppliers focus on robustness, lot-to-lot consistency, and compatibility with automated workflows, and service providers and contract research organizations differentiate themselves through domain expertise, turnaround times, and integrated multi-technique offerings.

Partnership strategies are increasingly central to competitive positioning; companies that combine hardware, software, and service capabilities through alliances or platform integrations are better placed to deliver end-to-end solutions that reduce friction for adopters. Moreover, a subset of companies is prioritizing modular offerings that allow customers to scale from single-technique projects to integrative pipelines as project complexity grows. Finally, attention to regulatory support, validation services, and training is becoming a meaningful differentiator, as end users seek vendors who not only supply equipment and reagents but also provide the methodological support needed to translate structural insights into downstream applications safely and efficiently.

Practical, high-impact recommendations for leaders to enhance interoperability, workforce capability, procurement resilience, and data governance across integrated workflows

Industry leaders should focus on actionable levers that unlock efficiency and scientific impact across integrated structural biology workflows. First, prioritizing interoperability between computational and experimental platforms reduces friction and accelerates validation cycles. By adopting open standards and investing in API-driven integrations, organizations can shorten the path from prediction to experimental confirmation. Second, investing in workforce development and cross-disciplinary training ensures that teams can exploit advanced techniques and interpret composite datasets effectively; sustained education programs and targeted skill-building reduce operational bottlenecks and enhance reproducibility.

Third, re-evaluating procurement and supply-chain strategies to incorporate resilience against trade disruptions and tariff fluctuations will safeguard research continuity; diversified sourcing, shared core facilities, and strategic partnerships with regional providers can mitigate exposure. Fourth, embracing modular service models and partnerships enables organizations to scale capabilities in line with project needs rather than committing immediately to high capital expenditures. Finally, leaders should embed robust data governance, FAIR data principles, and reproducible pipelines into their operational practices to maximize the long-term utility of structural datasets and to facilitate collaboration across institutions and geographies. Collectively, these actions will strengthen scientific output and create durable operational advantages.

Transparent and rigorous mixed-methods research approach combining expert interviews, technical literature synthesis, comparative matrices, and applied validation exercises

The research methodology blends literature synthesis, expert interviews, technology landscape mapping, and validation against real-world use cases to ensure analytic rigor and relevance. Primary qualitative inputs include structured interviews with academic investigators, heads of core facilities, research directors in biotechnology and pharmaceutical companies, and technical leads at instrumentation and software firms. These conversations inform the technical evaluation of methods, operational constraints, and adoption drivers. Secondary sources encompass peer-reviewed literature, conference proceedings, technical whitepapers, and vendor documentation to triangulate capabilities, typical applications, and recent advancements.

Analytical methods include comparative technique matrices, workflow gap analysis, and scenario-based assessments of procurement and operational strategies. Case studies illustrate practical applications and the interplay of methods across discovery and translational settings. Throughout, emphasis is placed on methodological transparency, reproducible analytic logic, and clear articulation of assumptions to allow users to adapt insights to their specific organizational contexts. Where appropriate, validation exercises with domain experts were used to refine interpretations and to ensure the research reflects contemporary practice and emerging trends in structural biology and molecular modeling.

A concise conclusion highlighting the strategic imperatives to operationalize integrated structural biology approaches for durable scientific and translational gains

The cumulative evidence underscores a field in active transition toward integrated, data-driven structural discovery workflows. Experimental advances and computational innovations are mutually reinforcing, producing a virtuous cycle that expands the range of tractable biological questions and accelerates translational impact. Stakeholders who prioritize interoperability, workforce capability, and resilient procurement are best positioned to convert technological potential into reproducible scientific outcomes and strategic advantage. As modalities become more complementary, organizations will derive the greatest value from thoughtfully constructed multi-technique pipelines that align methods to specific scientific objectives and operational constraints.

Looking forward, sustained attention to data standards, open interfaces, and collaborative models will be essential to scale integrative approaches across diverse institutional contexts. By focusing on these foundational elements-technology alignment, human capital, and supply-chain resilience-research organizations and commercial entities can harness current innovations to drive more efficient discovery, reliable development pathways, and impactful translational outcomes informed by high-quality structural insight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Structural Biology & Molecular Modeling Techniques Market, by Technique

  • 8.1. Computational Modeling
    • 8.1.1. Ab Initio Modeling
    • 8.1.2. Homology Modeling
    • 8.1.3. Molecular Dynamics
  • 8.2. Cryo-Em
    • 8.2.1. Single Particle Analysis
    • 8.2.2. Tomography
  • 8.3. Mass Spectrometry
    • 8.3.1. Esi
    • 8.3.2. Maldi-Tof
  • 8.4. Nmr Spectroscopy
    • 8.4.1. Solid State Nmr
    • 8.4.2. Solution Nmr
  • 8.5. X-Ray Crystallography
    • 8.5.1. Powder
    • 8.5.2. Single-Crystal

9. Structural Biology & Molecular Modeling Techniques Market, by Product Type

  • 9.1. Instruments
  • 9.2. Reagents And Consumables
    • 9.2.1. Enzymes
    • 9.2.2. Kits
  • 9.3. Services
  • 9.4. Software

10. Structural Biology & Molecular Modeling Techniques Market, by Workflow Step

  • 10.1. Data Collection
    • 10.1.1. Automated Collection
    • 10.1.2. Manual Collection
  • 10.2. Data Processing
  • 10.3. Sample Preparation
  • 10.4. Visualization

11. Structural Biology & Molecular Modeling Techniques Market, by Application

  • 11.1. Biomarker Discovery
  • 11.2. Drug Discovery
    • 11.2.1. Lead Identification
    • 11.2.2. Lead Optimization
  • 11.3. Protein Engineering
  • 11.4. Structure Function Analysis

12. Structural Biology & Molecular Modeling Techniques Market, by End User

  • 12.1. Academic Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical Companies

13. Structural Biology & Molecular Modeling Techniques Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Structural Biology & Molecular Modeling Techniques Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Structural Biology & Molecular Modeling Techniques Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Structural Biology & Molecular Modeling Techniques Market

17. China Structural Biology & Molecular Modeling Techniques Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Atomwise Inc.
  • 18.6. BioSolveIT GmbH
  • 18.7. Biosym Technologies
  • 18.8. Certara, L.P.
  • 18.9. Chemical Computing Group ULC
  • 18.10. Compugen Ltd.
  • 18.11. Cresset BioMolecular Discovery Ltd.
  • 18.12. Cresset Group Limited
  • 18.13. Cyclica Inc.
  • 18.14. Cytiva
  • 18.15. Dassault Systemes SE
  • 18.16. Genedata AG
  • 18.17. Moleculon, Inc.
  • 18.18. Molsoft LLC
  • 18.19. NanoTemper Technologies GmbH
  • 18.20. Nimbus Therapeutics, Inc.
  • 18.21. OpenEye Scientific Software, Inc.
  • 18.22. Relay Therapeutics, Inc.
  • 18.23. Schrodinger, Inc.
  • 18.24. Simulations Plus, Inc.
  • 18.25. Tripos International

LIST OF FIGURES

  • FIGURE 1. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AB INITIO MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AB INITIO MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AB INITIO MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE PARTICLE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE PARTICLE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE PARTICLE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ESI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ESI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ESI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MALDI-TOF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MALDI-TOF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLID STATE NMR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLID STATE NMR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLID STATE NMR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLUTION NMR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLUTION NMR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLUTION NMR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE-CRYSTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE-CRYSTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE-CRYSTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AUTOMATED COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AUTOMATED COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AUTOMATED COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MANUAL COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MANUAL COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MANUAL COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STRUCTURE FUNCTION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STRUCTURE FUNCTION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STRUCTURE FUNCTION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NMR SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COMPUTATIONAL MODELING, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-EM, 2018-2032 (US